Please login to the form below

Not currently logged in
Email:
Password:

Dr Martin Rothman joins Sofinnova Partners

He becomes the firm’s venture partner

RothmanLife Science-focused European venture capital firm, Sofinnova Partners, has appointed Dr Martin Rothman as venture partner.

Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. There, he will focus on helping the team identify and evaluate “promising” medical device companies.

His new position at the firm will also see him take on a mentor role, as he will guide entrepreneurs and physicians launching clinical innovations.

Rothman said: “I am thrilled to join Sofinnova Partners’ team as venture partner.

“We share a common vision of entrepreneurship and a passion for bringing innovative therapies to patients and the medical community.”

Until recently, Rothman was vice president of medical affairs for coronary, structural heart and renal denervation for Medtronic, where he held that position since 2010.

Commenting on the appointment, Antoine Papiernik, managing partner and chairman of Sofinnova Partners, said: “Martin is an exceptional physician and repeat entrepreneur.

“His experience ideally complements our team and represents a key asset for Sofinnova Partners at a time when our activity is growing.”

22nd May 2018

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics